- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Morepen Laboratories Limited — Updates, 17-04-2026: Press Release
17-04-2026 | 02:24 pm
17-04-2026 | 02:24 pm
Morepen's Masulkhana API facility successfully passed its USFDA inspection with zero observations (NIL Form 483) for the fourth time. This strengthens global credibility, boosts market position, and enables long-term supply contracts, aiding its CDMO expansion.
No comments yet. Be the first to comment!